Gray Michael sold 853 shares of Upstream Bio, Inc. at $5.49 per share on 2026-09-16, leaving 27,942 shares. The transaction represented about 3.0% of his prior holding, giving investors the stated size, price and resulting ownership tied to the insider transaction.
Key Highlights
- Gray Michael’s sale was priced at $5.49 per Upstream Bio share.
- The transaction reduced his prior holding by about 3.0%.
- Gray Michael retained 27,942 Upstream Bio shares after the sale.
Gray Michael sold 853 shares of Upstream Bio, Inc. (NASDAQ: UPB) at $5.49 per share, setting the reported size and price of the insider transaction. The sale took place on 16 September 2026. After the transaction, his reported position stood at 27,942 shares. The 853 shares covered by the transaction were priced individually at $5.49. The resulting ownership figure records Gray Michael’s position after the transaction. Upstream Bio, Inc. is the named company associated with the shares.
Sale Equalled 3.0% of Prior Holding
Measured against Gray Michael’s earlier Upstream Bio shareholding, the transaction represented about 3.0%. That percentage refers to his prior holding rather than the resulting 27,942-share position. Gray Michael’s remaining position is stated after the sale was completed.
FAQs
Q: What price did Gray Michael receive for the Upstream Bio shares?
A: Gray Michael sold the Upstream Bio shares at $5.49 per share. The transaction occurred on 16 September 2026.
Q: How many Upstream Bio shares did Gray Michael own after the sale?
A: Gray Michael held 27,942 Upstream Bio shares after the transaction. He is identified as the company’s CFO and COO.
Q: What does transaction code S mean in Gray Michael’s Upstream Bio sale?
A: The reported transaction involved Gray Michael selling 853 shares of Upstream Bio, Inc. The shares were sold at $5.49 per share on 16 September 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.